Bausch+Lomb Results Presentation Deck
Segment Financials
Vision Care
Contact Lens Revenue
Consumer Revenue
Total Revenue
Surgical
Implantables Revenue
Equipment Revenue
Consumables Revenue
Total Revenue
Ophthalmic Pharmaceuticals
Total Revenue
BAUSCH + LOMB
3Q22
$222M
$376M
$598M
3Q22
$47M
$34M
$91M
$172M
3Q22
$172M
3Q21
$226M
$379M
$605M
3Q21
$45M
$35M
$93M
$173M
3Q21
$171M
Reported Change
(2%)
(1%)
(1%)
Reported Change
4%
(3%)
(2%)
(1%)
Reported Change
1%
1. This is a non-GAAP measure or ratio. See Slide 2 and this Appendix for further information on non-GAAP measures and ratios.
2. Organic revenue growth/change, a non-GAAP ratio, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and discontinuations.
Organic Change %¹,2
6%
3%
4%
Organic Change % ¹,2
14%
3%
6%
8%
Organic Change %¹,2
5%
30View entire presentation